Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Contrast Media × Dermatologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7 Thoracic 6 Gastrointestinal 5 Genitourinary 4 Sarcoma 3 Head & Neck 3 Breast 3 Gynecologic 2 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Endocrine 1 Dermatologic 1

Conditions

Melanoma 1 Lung Neoplasms 1

Interventions

pembrolizumab 337 Nivolumab 305 Ipilimumab 274 Cyclophosphamide 194 aldesleukin 148 Interleukin-2 110 fludarabine phosphate 106 trametinib 85 Temozolomide 83 Dacarbazine 81 fludarabine 80 dabrafenib 77 Radiotherapy 75 Biopsy 75 Vemurafenib 71 Imiquimod 53 Bevacizumab 51 sargramostim 50 Radiosurgery 49 Peripheral Blood Stem Cell Transplantation 49 Paclitaxel 49 Aminolevulinic Acid 49 binimetinib 48 Magnetic Resonance Spectroscopy 48 Carboplatin 48 Blood Specimen Collection 47 cemiplimab 46 Specimen Handling 46 Cisplatin 45 3-ingenyl angelate 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡